Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy
出版年份 2016 全文链接
标题
Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy
作者
关键词
Nasopharyngeal carcinoma, Gene amplification, EIF5A2, Prognosis
出版物
BMC CANCER
Volume 16, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-08-22
DOI
10.1186/s12885-016-2714-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Ablation of EIF5A2 induces tumor vasculature remodeling and improves tumor response to chemotherapy via regulation of matrix metalloproteinase 2 expression
- (2015) Feng-Wei Wang et al. Oncotarget
- EIF5A2 predicts outcome in localised invasive bladder cancer and promotes bladder cancer cell aggressiveness in vitro and in vivo
- (2014) J-H Wei et al. BRITISH JOURNAL OF CANCER
- Increased Expression of EIF5A2, Via Hypoxia or Gene Amplification, Contributes to Metastasis and Angiogenesis of Esophageal Squamous Cell Carcinoma
- (2014) Yan Li et al. GASTROENTEROLOGY
- EIF5A2 is a novel chemoresistance gene in breast cancer
- (2014) Yu Liu et al. Breast Cancer
- An Epidemiological and Molecular Study of the Relationship Between Smoking, Risk of Nasopharyngeal Carcinoma, and Epstein–Barr Virus Activation
- (2012) Feng-Hua Xu et al. JNCI-Journal of the National Cancer Institute
- Expression of ERCC1 predicts clinical outcome in locoregionally advanced nasopharyngeal carcinoma treated with cisplatin-based induction chemotherapy
- (2012) Pei-Yu Huang et al. ORAL ONCOLOGY
- Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches
- (2012) Kwok-Wai Lo et al. SEMINARS IN CANCER BIOLOGY
- Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs
- (2011) Alissa Michelle Go Wong et al. CANCER
- Current treatment of nasopharyngeal carcinoma
- (2011) Anthony T.C. Chan EUROPEAN JOURNAL OF CANCER
- Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial–mesenchymaltransition
- (2011) Wei Zhu et al. GUT
- Nasopharyngeal carcinoma: The next challenges
- (2010) Albiruni R.A. Razak et al. EUROPEAN JOURNAL OF CANCER
- Overexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non-small cell lung cancer patients
- (2010) Li-Ru He et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical Outcomes and Patterns of Failure After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma
- (2010) Wai Tong Ng et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- How Does Intensity-Modulated Radiotherapy Versus Conventional Two-Dimensional Radiotherapy Influence the Treatment Results in Nasopharyngeal Carcinoma Patients?
- (2010) Shu-Zhen Lai et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Randomized Trial of Radiotherapy Plus Concurrent-Adjuvant Chemotherapy vs Radiotherapy Alone for Regionally Advanced Nasopharyngeal Carcinoma
- (2010) A. W. M. Lee et al. JNCI-Journal of the National Cancer Institute
- Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma
- (2009) Dong-Jiang Tang et al. HEPATOLOGY
- Amplicons on chromosome 3 contain oncogenes induced by recurrent exposure to 12-O-tetradecanoylphorbol-13-acetate and sodium n-butyrate and Epstein–Barr virus reactivation in a nasopharyngeal carcinoma cell line
- (2008) Chia-Huei Lee et al. CANCER GENETICS AND CYTOGENETICS
- Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: Current and future directions
- (2008) Brigette B. Y. Ma et al. CANCER SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started